PD-L1 expression in microvascular endothelial cells predicts the efficacy and side effects of anlotinib

PD-L1 expression in microvascular endothelial cells predicts the efficacy and side effects of anlotinib

BackgroundImmunotherapy plays a crucial role in the treatment of tumors. However, few studies have investigated the relationship between the expression of Programmed Cell Death Ligand 1 (PD-L1, CD274) in microvascular endothelial cells (MECs), including blood endothelial cells (BECs) and lymphatic e...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingfang Feng, Yuan Gao, Shaochuan Liu, Tingting Qin, Yan Zhang, Jing Wang, Kai Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
anlotinib
PD-L1
microvascular endothelial cells
immune checkpoints
melanoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1544278/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1544278/full

Similar Items